Mega Lifesciences Public Co. Ltd.(TH:MEGA)
฿35.50+0.00 (+0.71%)
TH:MEGA
Mega Lifesciences Public Co. Ltd. financials statements
฿35.50
At close:+0.00 (+0.71%)
Mega Lifesciences Public Co. Ltd. (MEGA) Ratios
Mega Lifesciences Public Co. Ltd. Ratios
TH:MEGA's free cash flow for Q2 2026 was ฿14.73M. For the 2026 fiscal year, TH:MEGA's free cash flow was decreased by ฿-158.29M and operating cash flow was ฿173.01M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.23 | 2.61 | 2.25 | 1.91 | 1.92 |
| Quick Ratio | 1.61 | 1.84 | 1.49 | 1.17 | 1.13 |
| Cash Ratio | 0.84 | 0.88 | 0.53 | 0.44 | 0.45 |
| Solvency Ratio | 0.38 | 0.53 | 0.44 | 0.43 | 0.42 |
| Operating Cash Flow Ratio | 0.55 | 0.61 | 0.43 | 0.36 | 0.56 |
| Short-Term Operating Cash Flow Coverage | 5.94 | 8.35 | 25.35 | 8.71 | 16.21 |
| Net Current Asset Value | ฿ 5.57B | ฿ 5.89B | ฿ 4.77B | ฿ 4.72B | ฿ 4.05B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.03 | 0.02 | 0.03 | 0.03 |
| Debt-to-Equity Ratio | 0.07 | 0.05 | 0.03 | 0.05 | 0.04 |
| Debt-to-Capital Ratio | 0.06 | 0.05 | 0.03 | 0.05 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.57 | 1.44 | 1.56 | 1.67 | 1.66 |
| Debt Service Coverage Ratio | 4.27 | 7.16 | 21.54 | 9.85 | 11.43 |
| Interest Coverage Ratio | 52.70 | 87.54 | 92.93 | 94.72 | 76.98 |
| Debt to Market Cap | 0.02 | 0.01 | 0.00 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.85 | 0.61 | 0.32 | 0.52 | 0.44 |
| Net Debt to EBITDA | -1.31 | -1.11 | -0.82 | -0.70 | -0.71 |
| Profitability Margins | |||||
| Gross Profit Margin | 51.37% | 50.54% | 44.51% | 44.88% | 41.81% |
| EBIT Margin | 17.38% | 15.58% | 14.62% | 16.72% | 16.31% |
| EBITDA Margin | 19.39% | 17.43% | 16.44% | 18.46% | 18.26% |
| Operating Profit Margin | 20.52% | 21.96% | 18.52% | 17.35% | 15.40% |
| Pretax Profit Margin | 16.99% | 15.33% | 14.42% | 16.54% | 16.11% |
| Net Profit Margin | 13.51% | 13.12% | 12.71% | 14.29% | 13.77% |
| Continuous Operations Profit Margin | 13.51% | 13.12% | 12.71% | 14.28% | 13.74% |
| Net Income Per EBT | 79.53% | 85.56% | 88.11% | 86.39% | 85.50% |
| EBT Per EBIT | 82.83% | 69.80% | 77.87% | 95.33% | 104.61% |
| Return on Assets (ROA) | 11.95% | 14.16% | 13.72% | 15.30% | 14.67% |
| Return on Equity (ROE) | 18.72% | 20.38% | 21.42% | 25.54% | 24.33% |
| Return on Capital Employed (ROCE) | 26.63% | 32.73% | 28.80% | 29.88% | 25.86% |
| Return on Invested Capital (ROIC) | 20.18% | 27.08% | 25.08% | 24.94% | 21.47% |
| Return on Tangible Assets | 13.01% | 15.61% | 15.09% | 16.83% | 16.33% |
| Earnings Yield | 6.55% | 6.96% | 5.47% | 5.50% | 4.42% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.04 | 4.91 | 4.73 | 4.82 | 5.19 |
| Payables Turnover | 4.00 | 4.50 | 4.52 | 3.10 | 3.26 |
| Inventory Turnover | 2.19 | 2.50 | 2.58 | 2.10 | 2.15 |
| Fixed Asset Turnover | 5.87 | 6.93 | 7.05 | 7.29 | 6.72 |
| Asset Turnover | 0.88 | 1.08 | 1.08 | 1.07 | 1.07 |
| Working Capital Turnover Ratio | 2.25 | 2.59 | 2.96 | 3.30 | 3.62 |
| Cash Conversion Cycle | 165.85 | 139.22 | 138.06 | 131.18 | 127.80 |
| Days of Sales Outstanding | 90.26 | 74.40 | 77.13 | 75.66 | 70.27 |
| Days of Inventory Outstanding | 166.85 | 145.86 | 141.66 | 173.43 | 169.65 |
| Days of Payables Outstanding | 91.26 | 81.03 | 80.74 | 117.92 | 112.13 |
| Operating Cycle | 257.11 | 220.26 | 218.80 | 249.09 | 239.92 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.22 | 2.76 | 2.21 | 2.29 | 3.13 |
| Free Cash Flow Per Share | 2.46 | 2.47 | 1.87 | 1.93 | 2.94 |
| Dividend Paid and CapEx Coverage Ratio | 1.36 | 1.45 | 1.12 | 1.16 | 2.52 |
| Capital Expenditure Coverage Ratio | 4.23 | 9.33 | 7.01 | 6.38 | 17.07 |
| Operating Cash Flow Coverage Ratio | 4.11 | 4.89 | 7.65 | 4.74 | 7.65 |
| Operating Cash Flow to Sales Ratio | 0.20 | 0.16 | 0.12 | 0.13 | 0.19 |
| Free Cash Flow Yield | 7.34% | 7.42% | 4.49% | 4.13% | 5.83% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 15.30 | 14.39 | 18.23 | 18.19 | 22.65 |
| Price-to-Sales (P/S) Ratio | 2.06 | 1.88 | 2.32 | 2.60 | 3.11 |
| Price-to-Book (P/B) Ratio | 2.86 | 2.93 | 3.91 | 4.64 | 5.50 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.63 | 13.48 | 22.29 | 24.21 | 17.15 |
| Price-to-Operating Cash Flow Ratio | 10.40 | 12.04 | 18.89 | 20.41 | 16.15 |
| Price-to-Earnings Growth (PEG) Ratio | -2.94 | 16.48 | -1.67 | 1.19 | 0.58 |
| Enterprise Value Multiple | 9.34 | 9.70 | 13.30 | 13.38 | 16.34 |
| Enterprise Value | 25.61B | 25.94B | 34.30B | 38.73B | 42.19B |
| EV to EBITDA | 9.34 | 9.70 | 13.30 | 13.38 | 16.34 |
| EV to Sales | 1.81 | 1.69 | 2.19 | 2.47 | 2.98 |
| EV to Free Cash Flow | 11.95 | 12.10 | 21.00 | 23.00 | 16.43 |
| EV to Operating Cash Flow | 9.12 | 10.80 | 17.80 | 19.40 | 15.47 |
| Tangible Book Value Per Share | 10.23 | 9.84 | 9.16 | 8.54 | 7.65 |
| Shareholders’ Equity Per Share | 11.72 | 11.36 | 10.67 | 10.07 | 9.18 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.14 | 0.12 | 0.14 | 0.15 |
| Revenue Per Share | 16.23 | 17.65 | 17.99 | 17.99 | 16.21 |
| Net Income Per Share | 2.19 | 2.31 | 2.29 | 2.57 | 2.23 |
| Tax Burden | 0.80 | 0.86 | 0.88 | 0.86 | 0.86 |
| Interest Burden | 0.98 | 0.98 | 0.99 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.30 | 0.27 | 0.26 | 0.27 | 0.26 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.47 | 1.19 | 0.97 | 0.89 | 1.40 |
Currency in THB
